Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Reversal by inhibiting XBP1 activation of glucose deprivation-induced tolerance to multiple anticancer therapies
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jeong, Mini | - |
| dc.contributor.author | Jo, Serin | - |
| dc.contributor.author | Park, Serkin | - |
| dc.contributor.author | Sohn, Jeongwon | - |
| dc.contributor.author | Park, Yun Gyu | - |
| dc.date.accessioned | 2021-09-01T13:35:12Z | - |
| dc.date.available | 2021-09-01T13:35:12Z | - |
| dc.date.created | 2021-06-18 | - |
| dc.date.issued | 2019-07 | - |
| dc.identifier.issn | 0008-5472 | - |
| dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/64708 | - |
| dc.language | English | - |
| dc.language.iso | en | - |
| dc.publisher | AMER ASSOC CANCER RESEARCH | - |
| dc.title | Reversal by inhibiting XBP1 activation of glucose deprivation-induced tolerance to multiple anticancer therapies | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Jeong, Mini | - |
| dc.contributor.affiliatedAuthor | Park, Serkin | - |
| dc.identifier.doi | 10.1158/1538-7445.SABCS18-4745 | - |
| dc.identifier.wosid | 000488279405109 | - |
| dc.identifier.bibliographicCitation | CANCER RESEARCH, v.79, no.13 | - |
| dc.relation.isPartOf | CANCER RESEARCH | - |
| dc.citation.title | CANCER RESEARCH | - |
| dc.citation.volume | 79 | - |
| dc.citation.number | 13 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.